# Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects

> **NCT05574374** · PHASE1 · COMPLETED · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 36 (actual)

## Conditions studied

- Drug Drug Interaction

## Interventions

- **DRUG:** DWP14012
- **DRUG:** DWC202202
- **DRUG:** DWC202203

## Key facts

- **NCT ID:** NCT05574374
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-21
- **Primary completion:** 2023-03-06
- **Final completion:** 2023-03-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05574374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05574374, "Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05574374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*